Jagsonpal Pharmaceuticals Limited (BOM:507789)

Market Cap	11.68B -17.5%
Revenue (ttm)	2.82B +11.0%
Net Income	409.03M -21.8%
EPS	6.07 -22.1%
Shares Out	n/a
PE Ratio	28.55
Forward PE	n/a
Dividend	2.50 (1.39%)
Ex-Dividend Date	Sep 12, 2025

Volume	1,275
Average Volume	4,404
Open	177.05
Previous Close	179.15
Day's Range	172.85 - 178.30
52-Week Range	154.90 - 301.80
Beta	n/a
RSI	46.39
Earnings Date	Jan 21, 2026

About Jagsonpal Pharmaceuticals

Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally. It offers pharmaceutical formulations and products in the areas of gynaecology, orthopaedics, dermatology, and paediatrics. The company provides drugs in the form of tablets, softgels, injections, capsules, and syrups. Jagsonpal Pharmaceuticals Limited was incorporated in 1978 and is based in Gurugram, India.

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1978
• Employees: 1,399
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 507789

Financial Performance

In fiscal year 2025, Jagsonpal Pharmaceuticals's revenue was 2.69 billion, an increase of 28.76% compared to the previous year's 2.09 billion. Earnings were 553.61 million, an increase of 146.45%.